BioCentury This Week Ep. 171 - 2Q Markets Preview, Abortion Drug Rulings, Gilead Oncology
Apr 17, 2023
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12
Introduction
00:00 • 3min
The Importance of Good Data in Biotech
02:55 • 2min
The TL1A Antibody Market: A Competitive Process
05:02 • 2min
The Importance of Positive Clinical Data in Biotech IPO Prospects
06:38 • 2min
The Cash Runway: What to Look for in 2019
08:32 • 1min
The Upturn in Biotech Investments
09:56 • 2min
The Supreme Court's Decision on Miffa-Pristone
11:40 • 2min
The Supreme Court's Role in the Case of Miffa-Pristone
13:21 • 2min
The Supreme Court's Overturning the Fifth Circuit's Decision on Drug Safety
15:17 • 3min
Gilead's Ambitions for a Top 10 Cancer Company
18:40 • 4min
How Kite Pharma Is Building a Successful Cancer Franchise
22:22 • 3min
The History of Gilead's Oncology Franchise
25:30 • 3min